| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |